Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds

Health
By Pam Belluck from NYT Health https://ift.tt/lGpexno
via IFTTT Drugs (Pharmaceuticals), Alzheimer's Disease, Leqembi (Drug), Research, Proteins, Clinical Trials A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women